Interventional Study to Assess Efficacy and Safety of Velmanase Alfa in Patients With Alpha Mannosidosis
Clinical trial NCT04031066 · WITHDRAWN
Trial details
- NCT number
- NCT04031066
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- WITHDRAWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-11
- Primary completion
- 2021-10-27
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.